Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
| Cash Flows From Operating Activities | ||||
| Accounts payable and accrued liabilities | 50 | -3 | 2 | 12 |
| Other Working Capital | 90 | -1 | 1 | 24 |
| Other Operating Activity | -150 | -77 | -51 | -124 |
| Operating Cash Flow | $-10 | $-81 | $-48 | $-89 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 0 | 50 | N/A |
| Debt Repayment | 0 | -99 | -25 | -25 |
| Common Stock Issued | N/A | N/A | 0 | 223 |
| Other Financing Activity | 0 | 10 | 0 | 73 |
| Financing Cash Flow | $0 | $-89 | $25 | $271 |
| Beginning Cash Position | 12 | 181 | 204 | 23 |
| End Cash Position | 2 | 12 | 181 | 204 |
| Net Cash Flow | $-10 | $-169 | $-23 | $182 |
| Free Cash Flow | ||||
| Operating Cash Flow | -10 | -81 | -48 | -89 |
| Free Cash Flow | -10 | -81 | -48 | -89 |